Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • usfda

    Tag: usfda

    You Searched For "usfda"
    Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta

    Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta

    Medical Dialogues Bureau31 Aug 2019 9:30 AM IST
    Alimta is Lilly's third biggest-selling drug. The Indianapolis-based drugmaker reported second-quarter sales of $577.8 million for the medicine.U.S:...
    Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore

    Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore

    Farhat Nasim27 Aug 2019 2:30 PM IST
    "Strides Pharma Inc has acquired the manufacturing facility under an asset purchase agreement with Micelle Biopharma Inc for a consideration of USD...
    Alkem Labs gets 4 USFDA observations for St Louis facility

    Alkem Labs gets 4 USFDA observations for St Louis facility

    Medical Dialogues Bureau26 Aug 2019 12:39 PM IST
    New Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has received four observations from the US health regulator...
    Lupin, Glenmark recall hypertension, fungal infection drugs from US market

    Lupin, Glenmark recall hypertension, fungal infection drugs from US market

    Medical Dialogues Bureau26 Aug 2019 9:45 AM IST
    New Delhi: Pharma major Glenmark is recalling over 31,000 tubes of anti-fungal Clotrimazole and Betamethasone Dipropionate cream from the US market,...
    Lupin unveils generic version of Prozac tablets in US

    Lupin unveils generic version of Prozac tablets in US

    Medical Dialogues Bureau24 Aug 2019 9:45 AM IST
    Fluoxetine tablet is a generic version of Eli Lilly and Company's Prozac tablets in the same strengths, Lupin said.Mumba: Pharma major Lupin Limited...
    Granules India gets 2 USFDA observations for Chantilly facility

    Granules India gets 2 USFDA observations for Chantilly facility

    Medical Dialogues Bureau23 Aug 2019 11:46 AM IST
    "The United States Food and Drug Administration (USFDA) has completed inspection of the facility of Granules Pharmaceuticals Inc, a wholly-owned...
    Dr Reddys gets 8 USFDA observations for Duvvada facility in Andhra Pradesh

    Dr Reddys gets 8 USFDA observations for Duvvada facility in Andhra Pradesh

    Medical Dialogues Bureau21 Aug 2019 10:00 AM IST
    The audit of Dr Reddy's formulations manufacturing plant (Vizag SEZ Plant 1) at Duvvada, Visakhapatnam by the United States Food and Drug...
    Lupin gets USFDA approval for generic version of Westcort cream to treat skin conditions

    Lupin gets USFDA approval for generic version of Westcort cream to treat skin conditions

    Farhat Nasim18 Aug 2019 9:46 AM IST
    Hydrocortisone Valerate cream is a generic version of Sun Pharmaceutical Industries Ltd's Westcort cream in the same strength, Lupin added.New Delhi:...
    AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year

    AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year

    Medical Dialogues Bureau18 Aug 2019 9:36 AM IST
    A four-week supply of Humira, the world's best-selling medicine, has a list price of about $5,174, amounting to more than $60,000 for a year.U.S:...
    Lupin gets USFDA nod for generic version of Prozac tablets to treat depressive disorder

    Lupin gets USFDA nod for generic version of Prozac tablets to treat depressive disorder

    Medical Dialogues Bureau17 Aug 2019 9:45 AM IST
    The company has received approval for Fluoxetine Tablets from the US Food and Drug Administration(USFDA) to market its product which is a generic...
    Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month

    Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month

    Medical Dialogues Bureau17 Aug 2019 9:15 AM IST
    Rozlytrek was approved by the U.S. Food and Drug Administration on Thursday to treat certain types of solid tumours, which show rare genetic anomalies...
    Pfizer recalls 2 lots of migraine drug RELPAX over possible microbial contamination

    Pfizer recalls 2 lots of migraine drug RELPAX over possible microbial contamination

    Farhat Nasim17 Aug 2019 9:14 AM IST
    Lots of Pfizer Inc's Relpax were distributed nationwide to wholesalers, retailers, hospitals and healthcare providers in the 50 states and Puerto Rico...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok